ESCALON MEDICAL CORP 8-K

What Happened
Escalon Medical Corp. announced in an 8-K filed Jan 29, 2026 that it completed the sale of certain software-related assets tied to its AXIS platform to Optos Public Limited Company (Optos) under an Asset Purchase Agreement. The total purchase price is $3,000,000, payable in three milestone installments plus $25,000 previously paid on a term sheet. Escalon received the first milestone payment of $1,000,000 on January 23, 2026. The agreement includes customary representations, warranties, covenants, closing conditions and indemnification terms.

Key Details

• Sale price: $3,000,000 for AXIS-related software assets.
• Payment structure: three milestone installments; $1,000,000 received Jan 23, 2026; $25,000 was paid earlier upon term-sheet execution.
• Agreement: Asset Purchase Agreement with Optos filed as Exhibit 10.1 to the 8-K (certain annexes omitted per Regulation S-K).
• Financial reporting: Unaudited pro forma condensed consolidated financial statements reflecting the disposition are filed as Exhibit 99.1.

Why It Matters
The transaction produced an immediate $1.0M cash inflow and removes the specified AXIS software assets from Escalon’s balance sheet, with up to $2.0M of additional cash dependent on future milestones. Investors should note that remaining payments are contingent on milestone conditions (which may be outside the company’s control) and that the company provided pro forma financials to show the disposition’s effect. The filing also includes forward-looking statement disclosures about the uncertainty of future milestone payments.